Quest Diagnostics' Q4 Revenues up 7 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Quest Diagnostics today posted a 7 percent rise in fourth quarter revenues, topping analysts' estimates and helping drive an increase in its net income.

Quest's revenues from continuing operations were $1.88 billion for the three-month period ended Dec. 31, compared with year-ago revenues of $1.76 billion. Analysts had expected revenues of $1.85 billion.

The company said revenues from diagnostic information services climbed 7 percent over last year, while test volume around 9 percent. Revenue per requisition was nearly 2 percent lower than a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.